Coin World News reported that on August 13, according to Rockflow data, U.S. medical technology company ProPhase Labs surged over 35% during trading, raising its market value to $15.78 million. It had previously risen over 40% in pre-market trading. ProPhase Labs announced on July 21 that it is exploring a reverse merger with a company focused on cryptocurrency and will begin holding Bitcoin as part of a new digital asset reserve strategy.